Monday, May 25, 2020
For the first time the President of ASCO gave a lecture to our oncologists
Thoughts of ASCO President 2009-2010. Prof.D.Blayney.
Clinical trials. System within the system. Prof. Igor Bondarenko
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Final Results of a Phase III Trial
Results of the CONFIRM Phase III Trial Comparing Fulvestrant 250 mg With Fulvestrant 500 mg in Postmenopausal Women With Estrogen Receptor–Positive Advanced Breast Cancer
Terms and Conditions